EMAIL THIS PAGE TO A FRIEND

Journal of pediatric hematology/oncology

Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.


PMID 22246157

Abstract

Peripheral neuropathy is a well-known side effect of vincristine (VCR), a microtubule inhibitor commonly used to treat malignancies. Severe neurological adverse events can occur in patients with Charcot-Marie-Tooth disease (CMT) treated with VCR. Vindesine is also a microtubule inhibitor, which, like VCR, is widely used to treat malignancies. The case of an 11-year-old female patient with CMT type 1A who developed severe peripheral neuropathy induced by VCR given for her acute lymphoblastic leukemia is reported. Alternative treatment containing vindesine instead of VCR led to a successful outcome without a relapse of leukemia or neurological worsening of CMT.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

V4890
Vindesine sulfate salt hydrate, ≥95% (HPLC)
C43H55N5O7 · H2SO4 · xH2O